<DOC>
	<DOC>NCT01612065</DOC>
	<brief_summary>Misoprostol is an effective agent for cervical priming before office hysteroscopy, vaginal route is the best, optimum dose not yet known.</brief_summary>
	<brief_title>Optimum Misoprostol Dose Prior to Office Hysteroscopy</brief_title>
	<detailed_description>The investigators will compare between 2 different doses of vaginal misoprostol, group (1) 200 ug, group (2) 400 ug, 3hours prior to office hysteroscopy , Infertile patient, patients with abnormal bleeding and patient with recurrent abortion Outcome measure: pain score, easiness of the procedure, procedure time, complications</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Abortion, Habitual</mesh_term>
	<mesh_term>Metrorrhagia</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Female patient pre or postmenopausal undergo office hysteroscopy. Age: from 20 to 60. BMI between 18 and 30. PID or Heavy uterine bleeding Cervical malignancy. Symptoms suggestive of endometriosis . Any cervical abnormality such as pinhole cervix that would obviate passage of a catheter through the cervix.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Office hysteroscopy</keyword>
	<keyword>Cervical priming</keyword>
	<keyword>Misoprostol</keyword>
</DOC>